| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | 0.071 | 0.05 |
| mRNA | BRD-A02303741:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.069 | 0.05 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.068 | 0.05 |
| mRNA | necrosulfonamide | CTRPv2 | pan-cancer | AAC | 0.074 | 0.05 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.05 |
| mRNA | BRD-K27188169 | CTRPv2 | pan-cancer | AAC | 0.099 | 0.05 |
| mRNA | Bortezomib | GDSC1000 | pan-cancer | AAC | -0.098 | 0.06 |
| mRNA | Ki8751 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.06 |
| mRNA | ATRA | CTRPv2 | pan-cancer | AAC | 0.065 | 0.06 |
| mRNA | KHS101 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |